Peregrine Asset Advisers, Inc. Moderna, Inc. Transaction History

Peregrine Asset Advisers, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$225.82 - $368.51 $536,548 - $875,579	-2,376 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$221.9 - $484.47 $29,068 - $63,465	131 Added 5.84%	2,376 $837,000
Q2 2021 Aug 12, 2021	BUY	$129.91 - $234.98 $31,827 - $57,570	245 Added 12.25%	2,245 $528,000
Q4 2020 Feb 04, 2021	BUY	$65.74 - $169.86 $131,480 - $339,720	2,000 New	2,000 $209,000

953

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Peregrine Asset Advisers, Inc., based on Form 13F filings with the SEC.

Stay updated on Peregrine Asset Advisers, Inc. with notifications on news.